0000899243-21-007194.txt : 20210218
0000899243-21-007194.hdr.sgml : 20210218
20210218185954
ACCESSION NUMBER: 0000899243-21-007194
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210203
FILED AS OF DATE: 20210218
DATE AS OF CHANGE: 20210218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bilenker Joshua H.
CENTRAL INDEX KEY: 0001612312
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39941
FILM NUMBER: 21651306
MAIL ADDRESS:
STREET 1: C/O LOXO ONCOLOGY, INC.
STREET 2: ONE LANDMARK SQUARE, SUITE 1122
CITY: STAMFORD
STATE: CT
ZIP: 06901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sana Biotechnology, Inc.
CENTRAL INDEX KEY: 0001770121
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 188 EAST BLAINE STREET, SUIT 400
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: (206) 701-7914
MAIL ADDRESS:
STREET 1: 188 EAST BLAINE STREET, SUIT 400
CITY: SEATTLE
STATE: WA
ZIP: 98102
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2021-02-03
2021-02-05
0
0001770121
Sana Biotechnology, Inc.
SANA
0001612312
Bilenker Joshua H.
C/O SANA BIOTECHNOLOGY, INC.
188 EAST BLAINE STREET, SUITE 400
SEATTLE
WA
98102
1
0
0
0
Stock Option (Right to Buy)
25.00
2021-02-03
4
A
0
11795
0.00
A
2031-02-02
Common Stock
11795
11795
D
This Form 4/A is being filed to correct a calculation error in regards to the number of option shares acquired.
The stock option shall vest and become exercisable in full on February 3, 2022.
/s/ James J. MacDonald, Attorney-in-Fact for Joshua H. Bilenker
2021-02-18